Duodenal ReCET

· Chinese University of Hong Kong

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Duodenal ReCET, covering 2026-01-29 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease [NA]